About Paragon Biosciences
Paragon Biosciences is a company based in Chicago (United States) founded in 2010 by Jeffrey S Aronin. Paragon Biosciences has raised $311.6 million across 7 funding rounds. Paragon Biosciences offers products and services including Innovative Therapies and Regenerative Medicines.
- Headquarter Chicago, United States
- Founders Jeffrey S Aronin
- Email••••••••
- Phone•••• ••••
- Website paragonbiosci.com
- Social LinkedIn X Facebook YouTube
- Legal Name Paragon Biosciences Llc
- Total Equity Funding$311.6M (USD)
in 7 rounds
- Latest Funding Round$185M (USD), Series E
Nov 2022
Products & Services of Paragon Biosciences
Paragon Biosciences offers a comprehensive portfolio of products and services, including Innovative Therapies and Regenerative Medicines.
Innovative therapies for patients with rare neurological diseases are developed and commercialized by the company.
Regenerative medicines that restore function for severe skin and connective tissue disorders are developed.
Apps and channels of Paragon Biosciences
its YouTube channel Paragon Biosciences has 80 subscribers and 23 videos.
Videos from Paragon Biosciences
The most watched videos on Paragon Biosciences's YouTube channel, Paragon Biosciences (80 subscribers). Click a video to play it here.
More on Paragon Biosciences.
Funding Insights of Paragon Biosciences
Paragon Biosciences has successfully raised a total of $311.6M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $185 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $311.6M
- Total Rounds 7
- Last Round Series E — $185M
- First Round $3.97M
(Aug 2018)
All 7 funding rounds of Paragon Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $185M | Series E | – | – | – |
| Nov 2022 | $25M | Series D | – | – | – |
| Mar 2021 | $35M | Series D | – | – | – |
| Dec 2020 | $15.84M | Series C | – | – | – |
| Oct 2019 | $37.42M | Series C | – | – | – |
| Dec 2018 | $9.38M | Series B | – | – | – |
| Aug 2018 | $3.97M | Series A | – | – | – |
People of Paragon Biosciences
13 people are tracked at Paragon Biosciences (7 in leadership, 1 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Jeffrey S Aronin | Founder & CEO | Leadership |
Spiro Katerinis | Chief Technology Officer | Leadership |
Darien Parhad | Chief Financial Officer | Leadership |
Robert Fincannon | Director Of Information Technology | Leadership |
Fran Subotic | Senior Director Of Accounting And HR Operations | Leadership |
Simone Blikstein | Director, Finance | Leadership |
Jenny Swalec | Vp, Regulatory Affairs | Leadership |
Kerensa Jimenez | CEO, Paragon Health Capital | Board & advisors |
Timothy Cunniff | EVP, Research & Development | Team |
Patrick Morris | EVP, Legal Affairs & General Counsel | Team |
Stephen Wanaski | SVP, Research & Exploratory Development | Team |
Jerilynn Jensen | Legal Assistant | Team |
Kathy Stoch | Manager HR Operations, Recruiting And Talent | Team |
Complete people profiles for Paragon Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Paragon Biosciences
3 dated milestones of Paragon Biosciences across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Paragon Biosciences is founded.
- Funding First funding round of $4.0M.
- Funding Latest funding round, Series E, of $185.0M.
Web traffic of Paragon Biosciences
The website of Paragon Biosciences (paragonbiosci.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▲ 9.1% vs previous month
Websites whose visitors overlap most with Paragon Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medexus.com | 100% | 6.4K | #3,239,042 | View details |
Latest news on Paragon Biosciences
Complete news archive for Paragon Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Paragon Biosciences
Paragon Biosciences was founded in 2010 and raised its 1st funding round 8 years after it was founded.
Paragon Biosciences is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
Jeffrey S Aronin is the current CEO of Paragon Biosciences. They have also founded this company.
Paragon Biosciences is a funded company, having raised a total of $311.6M across 7 funding rounds to date. The company's 1st funding round was a Series A of $3.97M, raised on Aug 2018.
Paragon Biosciences was founded in 2010 and is headquartered in Chicago, United States. Operations focus on the healthcare sector, where advisory services are offered to companies seeking strategic guidance. The firm is led by Jeffrey S. Aronin as founder and CEO. Expertise is applied across various healthcare subsectors, supporting decision-making and growth initiatives within the industry.
Paragon Biosciences offers Innovative Therapies and Regenerative Medicines.
Paragon Biosciences operates through Paragon Biosciences Llc.